ICRU Report No. 24 states that +- 5% is a reasonable degree of accuracy to strive for in the delivery of absorbed doses to target volumes in radiotherapy. To achieve this quality assurance level, a comprehensive programme comprising both physical and clinical components is needed. The purpose of this paper is to present the rationale and guidelines for implementing a recommended quality assurance programme. It will emphasize the physical aspects pertaining to acceptance and constancy tests using Cobalt-60 teletherapy units. It will also outline a suggested schedule of quality assurance testings including radiation dosimetry, geometry and electrochemical safety. (author).